Jane Street Group, LLC Nant Health, Inc. Transaction History

Jane Street Group, LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$0.38 - $0.61 $2,537 - $4,073	-6,678 Reduced 13.23%	43,784 $11,000
Q3 2022 Nov 14, 2022	SELL	$0.38 - $0.61 $2,537 - $4,073	-6,678 Reduced 13.23%	43,784 $11,000
Q2 2022 Aug 16, 2022	BUY	$0.42 - $0.78 $21,194 - $39,360	50,462 New	50,462 $21,000
Q3 2021 Nov 16, 2021	SELL	$1.61 - $2.41 $47,894 - $71,692	-29,748 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$2.25 - $3.37 $66,933 - $100,250	29,748 New	29,748 $69,000
Q4 2020 Feb 17, 2021	SELL	$1.96 - $3.56 $51,553 - $93,638	-26,303 Closed	0 $0
Q3 2020 Nov 17, 2020	SELL	$2.1 - $5.99 $63,856 - $182,143	-30,408 Reduced 53.62%	26,303 $62,000
Q2 2020 Aug 17, 2020	BUY	$1.45 - $4.99 $33,170 - $114,151	22,876 Added 67.61%	56,711 $260,000
Q1 2020 May 15, 2020	BUY	$0.97 - $2.27 $32,819 - $76,805	33,835 New	33,835 $54,000
Q1 2019 May 16, 2019	SELL	$0.52 - $1.33 $12,315 - $31,498	-23,683 Closed	0 $0
Q4 2018 Feb 15, 2019	BUY	$0.5 - $1.7 $11,841 - $40,261	23,683 New	23,683 $13,000

Ticker NH
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 115,550,000
Market Cap $48.5M
Description
NantHealth, Inc., together with its subsidiaries, operates as a healthcare IT company in the United States, Canada, and the United Kingdom. It offers Eviti, a software-as-a-service (SaaS) based clinical decision support solution that centralizes clinical content and treatment cost data from Medicare reimbursements and treatment toxicity data; Ev...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.